Search by Drug Name or NDC

NDC 65162-0455-03 Levomilnacipran 120 mg/1 Details

Levomilnacipran 120 mg/1

Levomilnacipran is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is LEVOMILNACIPRAN HYDROCHLORIDE.

MedlinePlus Drug Summary

Levomilnacipran is used to treat depression. Levomilnacipran is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of serotonin and norepinephrine, natural substances in the brain that helps maintain mental balance.

Related Packages: 65162-0455-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Levomilnacipran

Product Information

NDC	65162-0455
Product ID	65162-455_7149e393-2535-4c4b-96c6-dddecfe03493
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Levomilnacipran
Proprietary Name Suffix	n/a
Non-Proprietary Name	Levomilnacipran
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	120
Active Ingredient Units	mg/1
Substance Name	LEVOMILNACIPRAN HYDROCHLORIDE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA210790
Listing Certified Through	2024-12-31

Package

NDC 65162-0455-03 (65162045503)

Pricing Information	N/A
NDC Package Code	65162-455-03
Billing NDC	65162045503
Package	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-455-03)
Marketing Start Date	2019-02-04
NDC Exclude Flag	N